Your browser doesn't support javascript.
loading
Differences in SARS-CoV-2 Vaccine Response Dynamics Between Class-I- and Class-II-Specific T-Cell Receptors in Inflammatory Bowel Disease.
Xu, Alexander M; Li, Dalin; Ebinger, Joseph E; Mengesha, Emebet; Elyanow, Rebecca; Gittelman, Rachel M; Chapman, Heidi; Joung, Sandy; Botwin, Gregory J; Pozdnyakova, Valeriya; Debbas, Philip; Mujukian, Angela; Prostko, John C; Frias, Edwin C; Stewart, James L; Horizon, Arash A; Merin, Noah; Sobhani, Kimia; Figueiredo, Jane C; Cheng, Susan; Kaplan, Ian M; McGovern, Dermot P B; Merchant, Akil; Melmed, Gil Y; Braun, Jonathan.
Afiliação
  • Xu AM; Cedars Sinai Cancer and Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
  • Li D; F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
  • Ebinger JE; Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
  • Mengesha E; F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
  • Elyanow R; Adaptive Biotechnologies, Seattle, WA, United States.
  • Gittelman RM; Adaptive Biotechnologies, Seattle, WA, United States.
  • Chapman H; Adaptive Biotechnologies, Seattle, WA, United States.
  • Joung S; Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
  • Botwin GJ; F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
  • Pozdnyakova V; F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
  • Debbas P; F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
  • Mujukian A; F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
  • Prostko JC; Applied Research and Technology, Abbott Diagnostics, Abbott Park, IL, United States.
  • Frias EC; Applied Research and Technology, Abbott Diagnostics, Abbott Park, IL, United States.
  • Stewart JL; Applied Research and Technology, Abbott Diagnostics, Abbott Park, IL, United States.
  • Horizon AA; Center for Rheumatology Medical Group, Los Angeles, CA, United States.
  • Merin N; Cedars Sinai Cancer and Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
  • Sobhani K; Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
  • Figueiredo JC; Cedars Sinai Cancer and Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
  • Cheng S; Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
  • Kaplan IM; Adaptive Biotechnologies, Seattle, WA, United States.
  • McGovern DPB; F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
  • Merchant A; Cedars Sinai Cancer and Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
  • Melmed GY; F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
  • Braun J; F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
Front Immunol ; 13: 880190, 2022.
Article em En | MEDLINE | ID: mdl-35464463

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / COVID-19 Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / COVID-19 Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos